REGN5459
R5459-ONC-1888
Phase 2 small_molecule completed
Quick answer
REGN5459 for Relapsed Multiple Myeloma is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Relapsed Multiple Myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed